Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Design of the HPTN 065 (TLC-Plus) study: A study to evaluate the feasibility of an enhanced test, link-to-care, plus treat approach for HIV prevention in the United States.

Gamble T, Branson B, Donnell D, Hall HI, King G, Cutler B, Hader S, Burns D, Leider J, Wood AF, G Volpp K, Buchacz K, El-Sadr WM; HPTN 065 Study Team.

Clin Trials. 2017 Aug;14(4):322-332. doi: 10.1177/1740774517711682. Epub 2017 Jun 19.

2.

Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study.

King E, Kinvig K, Steif J, Qiu AQ, Maan EJ, Albert AY, Pick N, Alimenti A, Kestler MH, Money DM, Lester RT, Murray MCM.

J Med Internet Res. 2017 Jun 1;19(6):e190. doi: 10.2196/jmir.6631.

3.

A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.

Hayes R, Floyd S, Schaap A, Shanaube K, Bock P, Sabapathy K, Griffith S, Donnell D, Piwowar-Manning E, El-Sadr W, Beyers N, Ayles H, Fidler S; HPTN 071 (PopART) Study Team.

PLoS Med. 2017 May 2;14(5):e1002292. doi: 10.1371/journal.pmed.1002292. eCollection 2017 May.

4.

Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China.

Lou J, Hu P, Qian HZ, Ruan Y, Jin Z, Xing H, Shao Y, Vermund SH.

PLoS One. 2017 Apr 13;12(4):e0171295. doi: 10.1371/journal.pone.0171295. eCollection 2017.

5.

Prevalence and risk factors of HIV and syphilis, and knowledge and risk behaviors related to HIV/AIDS among men who have sex with men in Chongqing, China.

Ma W, Wu G, Zheng H, Zhang W, Peng Z, Yu R, Wang N.

J Biomed Res. 2016 Mar;30(2):101-111. doi: 10.7555/JBR.30.20150057. Epub 2015 Jun 11.

6.

Impact of Antiretroviral Therapy on the Spread of Human Immunodeficiency Virus in Chaoyang District, Beijing, China: Using the Asian Epidemic Model.

Tao LL, Liu M, Li SM, Liu J, Jiang SL, Wang LJ, Luo FJ, Wang N.

Chin Med J (Engl). 2017 5th Jan 2017;130(1):32-38. doi: 10.4103/0366-6999.196571.

7.

Human Resources for Treating HIV/AIDS: Are the Preventive Effects of Antiretroviral Treatment a Game Changer?

Bärnighausen T, Bloom DE, Humair S.

PLoS One. 2016 Oct 7;11(10):e0163960. doi: 10.1371/journal.pone.0163960. eCollection 2016.

8.

Late-stage disease at presentation to an HIV clinic in eastern Tanzania: A retrospective cross-sectional study.

Mhozya H, Bintabara D, Kibusi S, Neilson E, Mpondo BC.

Malawi Med J. 2015 Dec;27(4):125-7.

9.

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study.

Nichols BE, Götz HM, van Gorp EC, Verbon A, Rokx C, Boucher CA, van de Vijver DA.

PLoS One. 2015 Nov 10;10(11):e0142576. doi: 10.1371/journal.pone.0142576. eCollection 2015.

10.

Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model.

Caro-Vega Y, del Rio C, Lima VD, Lopez-Cervantes M, Crabtree-Ramirez B, Bautista-Arredondo S, Colchero MA, Sierra-Madero J.

PLoS One. 2015 Aug 24;10(8):e0136534. doi: 10.1371/journal.pone.0136534. eCollection 2015.

11.

Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes.

Lima VD, Reuter A, Harrigan PR, Lourenço L, Chau W, Hull M, Mackenzie L, Guillemi S, Hogg RS, Barrios R, Montaner JS.

AIDS. 2015 Sep 10;29(14):1871-82. doi: 10.1097/QAD.0000000000000790. Erratum in: AIDS. 2016 Feb 20;30(4):677.

12.

Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model.

Luo S, Han L, Lu H, Dou Z, Tao Q, Khoshnood K, Wu Z, Xu J.

PLoS One. 2015 Jun 3;10(6):e0126893. doi: 10.1371/journal.pone.0126893. eCollection 2015.

13.

A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa.

van Loggerenberg F, Gray D, Gengiah S, Kunene P, Gengiah TN, Naidoo K, Grant AD; CAPRISA 058 Study Team.

AIDS Patient Care STDS. 2015 May;29(5):299-306. doi: 10.1089/apc.2014.0293. Epub 2015 Feb 18.

14.

Optimizing an HIV testing program using a system dynamics model of the continuum of care.

Kok S, Rutherford AR, Gustafson R, Barrios R, Montaner JS, Vasarhelyi K; Vancouver HIV Testing Program Modelling Group.

Health Care Manag Sci. 2015 Sep;18(3):334-62. doi: 10.1007/s10729-014-9312-0. Epub 2015 Jan 17.

15.

HIV treatment as prevention: contradictory perspectives from dynamic mathematical models.

Wu J, Norris JL, Jia Y, Wang N.

ScientificWorldJournal. 2014;2014:760734. doi: 10.1155/2014/760734. Epub 2014 Dec 15. Review.

16.

Treatment as prevention--where next?

Hull M, Lange J, Montaner JS.

Curr HIV/AIDS Rep. 2014 Dec;11(4):496-504. doi: 10.1007/s11904-014-0237-5. Review.

17.

HIV treatment as prevention: the key to an AIDS-free generation.

Hull MW, Montaner JS.

J Food Drug Anal. 2013 Dec;21(4):S95-S101.

18.

Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.

Abebe M, Kinde S, Belay G, Gebreegziabxier A, Challa F, Gebeyehu T, Nigussie P, Tegbaru B.

BMC Res Notes. 2014 Jun 21;7:380. doi: 10.1186/1756-0500-7-380.

19.

Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction.

Sidibé M, Zuniga JM, Montaner J.

Clin Infect Dis. 2014 Jul;59 Suppl 1:S3-6. doi: 10.1093/cid/ciu321.

20.

Modeling scenarios for the end of AIDS.

Lima VD, Thirumurthy H, Kahn JG, Saavedra J, Cárceres CF, Whiteside A.

Clin Infect Dis. 2014 Jul;59 Suppl 1:S16-20. doi: 10.1093/cid/ciu339.

Supplemental Content

Support Center